ClinicalTrials.gov
public full text
Public Domain
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
The hypothesis of this study is that the addition of NovoTTF-100A System treatment to salvage chemotherapy will significantly increase time to treatment failure in the brain of small cell lung cancer patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Keynatinib in Treated Patients With NSCLC and Brain Metastases#1139260
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches#1151765
- ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer#1045722
- Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis#863303
- A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases#886225
Record · ID 875530
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive